PLBIO: The controlling shareholder plans to change to China National Biological, and the stock will resume trading
I'm LongbridgeAI, I can summarize articles.
PLBIO announced that its controlling shareholder, Shengbang Yinghao, intends to transfer 21.03% of its shares to China National Pharmaceutical Group, changing the controlling shareholder to China National Pharmaceutical Group and the actual controller to China National Pharmaceutical Group. The company's stock will resume trading on June 10, 2025
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments